Advances in adenovirus-mediated p53 cancer gene therapy.
about
Chemical Variations on the p53 Reactivation ThemeTumor suppressor p53 and its gain-of-function mutants in cancerArray-based genome-wide RNAi screening to identify shRNAs that enhance p53-related apoptosis in human cancer cellsClinical utility of recombinant adenoviral human p53 gene therapy: current perspectives.Evaluation of transduction properties of an adenovirus vector in neonatal mice.Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway.A p53-independent apoptotic mechanism of adenoviral mutant E1A was involved in its selective antitumor activity for human cancer.E1A-engineered human umbilical cord mesenchymal stem cells as carriers and amplifiers for adenovirus suppress hepatocarcinoma in mice.Historical and Clinical Experiences of Gene Therapy for Solid Cancers in China.Non-cell autonomous or secretory tumor suppression.Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells.p53 Replacement Therapy for Cancer.Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer.Safety and Efficacy in Advanced Solid Tumors of a Targeted Nanocomplex Carrying the p53 Gene Used in Combination with Docetaxel: A Phase 1b Study.Emerging drugs for head and neck cancer.A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters.Tumor angiogenesis and anti-angiogenic gene therapy for cancer.Inhibin B suppresses anoikis resistance and migration through the transforming growth factor-β signaling pathway in nasopharyngeal carcinoma
P2860
Q26749008-DC79B31E-A902-4ADD-BB61-6BAAC0A38EEBQ27000754-09E03A10-5715-4EC4-ABF0-DF306F4E78F5Q34365770-C506DCC9-DCB3-40BA-B837-2C1213C0C6E7Q34415371-D37AE673-FC1F-4DCB-A614-71AB2AF07440Q35649623-6B7F75A1-4B54-4E56-8D10-6BEFD8E6B970Q35871976-AB187186-32E5-4450-B0FD-D5E0B9506A02Q36262922-DF6E9ED0-EEF7-45D7-A283-AFEF37616B1AQ37565456-F8E86024-2461-4085-92CA-15382A8F2A54Q37588372-CE9B324C-5644-4884-86E6-83C98A5E778BQ37724094-A7C01634-A2CD-47F4-8A71-F4ACB79AE676Q38206143-3088556C-4321-48A3-BB19-A446650AA143Q38286386-CECE8EFD-F626-4BF4-9AB9-36674D131514Q38754849-16DA1A4F-39AA-453F-871F-A64671DDB3CEQ39094425-7A9E747F-D69D-4077-9294-1D8FE5BFC45DQ39429511-DEA28F40-5694-49CC-B284-B9A127BE0E08Q42367187-92B9D56B-5601-4F96-AF9F-7D33117C2C56Q45874449-7E8FFF0E-CCAF-4A3A-B234-F214F760991FQ49746069-3B349A9B-B16B-4461-A9EB-8CDE2ABA1C19Q55385227-5D409ECF-4278-477E-B665-282A46AF1773Q58719354-44AFB4DC-1F16-4D14-A36A-FC5C4B2B0DB2
P2860
Advances in adenovirus-mediated p53 cancer gene therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Advances in adenovirus-mediated p53 cancer gene therapy.
@en
type
label
Advances in adenovirus-mediated p53 cancer gene therapy.
@en
prefLabel
Advances in adenovirus-mediated p53 cancer gene therapy.
@en
P2860
P1476
Advances in adenovirus-mediated p53 cancer gene therapy.
@en
P2093
Toshiyoshi Fujiwara
P2860
P304
P356
10.1517/14712598.2013.845662
P407
P577
2013-11-01T00:00:00Z